Open main menu
Blog HomeProductContact

Rheumatology

"Will Not Be an Easy Protocol." How Tekton Went From a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.
Case Study
•

"Will Not Be an Easy Protocol." How Tekton Went From a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.

UCB's bimekizumab protocol had 42 eligibility criteria across two disease cohorts. Tekton Research used HealthKey to screen 650 patients and surface 14 qualified candidates in 11 days, 2.8x the enrollment target, for a trial the site couldn't have staffed manually.

"I Was Doing This by Hand for a Year." How Tekton Research Cut RA Trial Chart Review by 97%.
Case Study
•

"I Was Doing This by Hand for a Year." How Tekton Research Cut RA Trial Chart Review by 97%.

Tekton’s Site Manager was manually screening 1,300 rheumatoid arthritis patient charts for a Merck Phase 2b trial. HealthKey processed 2,087 patients and 1.7 million medical records, narrowing her review to 40 charts and saving 626 hours.